170 related articles for article (PubMed ID: 26566624)
1. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.
Yin MZ; Tan S; Li X; Hou Y; Cao G; Li K; Kou J; Lou G
Tumour Biol; 2016 Apr; 37(4):5485-92. PubMed ID: 26566624
[TBL] [Abstract][Full Text] [Related]
2. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
3. Quantification of lysophosphatidylcholines and phosphatidylcholines using liquid chromatography-tandem mass spectrometry in neonatal serum.
Takatera A; Takeuchi A; Saiki K; Morisawa T; Yokoyama N; Matsuo M
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):31-6. PubMed ID: 16603422
[TBL] [Abstract][Full Text] [Related]
4. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Zhong L; Cheng F; Lu X; Duan Y; Wang X
Talanta; 2016 Sep; 158():351-360. PubMed ID: 27343615
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients.
Okita M; Gaudette DC; Mills GB; Holub BJ
Int J Cancer; 1997 Mar; 71(1):31-4. PubMed ID: 9096662
[TBL] [Abstract][Full Text] [Related]
7. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
[TBL] [Abstract][Full Text] [Related]
8. UPLC-MS-based serum metabonomics for identifying acute liver injury biomarkers in Chinese miniature pigs.
Ma J; Yu J; Su X; Zhu C; Yang X; Sun H; Chen D; Wang Y; Cao H; Lu J
Toxicol Lett; 2014 Mar; 225(3):358-66. PubMed ID: 24451218
[TBL] [Abstract][Full Text] [Related]
9. A new approach for characterization of phosphatidylcholines and
Khedr A; Khayat MT; Khayyat AN
Bioanalysis; 2020 Feb; 12(3):191-204. PubMed ID: 31983213
[No Abstract] [Full Text] [Related]
10. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P
Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine--biomarker of Metformin action: studied using UPLC/MS/MS.
Cai S; Huo T; Li N; Xiong Z; Li F
Biomed Chromatogr; 2009 Jul; 23(7):782-6. PubMed ID: 19309761
[TBL] [Abstract][Full Text] [Related]
12. Four Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting Cervical Cancer.
Sun W; Wang L; Zhao D; Wang P; Li Y; Wang S
Gynecol Obstet Invest; 2018; 83(6):533-539. PubMed ID: 30134241
[TBL] [Abstract][Full Text] [Related]
13. Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics.
Zhou H; Li Q; Wang T; Liang H; Wang Y; Duan Y; Song M; Wang Y; Jin H
Medicine (Baltimore); 2019 Jun; 98(26):e16192. PubMed ID: 31261558
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric identification of molecular species of phosphatidylcholine and lysophosphatidylcholine extracted from shark liver.
Chen S; Li KW
J Agric Food Chem; 2007 Nov; 55(23):9670-7. PubMed ID: 17949052
[TBL] [Abstract][Full Text] [Related]
15. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
Zhao Z; Xiao Y; Elson P; Tan H; Plummer SJ; Berk M; Aung PP; Lavery IC; Achkar JP; Li L; Casey G; Xu Y
J Clin Oncol; 2007 Jul; 25(19):2696-701. PubMed ID: 17602074
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
[TBL] [Abstract][Full Text] [Related]
17. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
18. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer.
You W; Wang Y; Zheng J
Reprod Sci; 2015 Aug; 22(8):1037-41. PubMed ID: 25701838
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease.
Miletić Vukajlović J; Drakulić D; Pejić S; Ilić TV; Stefanović A; Petković M; Schiller J
Rapid Commun Mass Spectrom; 2020 Feb; 34(4):e8595. PubMed ID: 31519070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
